Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000775602 | SCV000909966 | likely benign | Familial hypercholesterolemia | 2017-08-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000775602 | SCV002448032 | likely benign | Familial hypercholesterolemia | 2023-08-11 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004001452 | SCV004842036 | likely benign | Hypercholesterolemia, familial, 1 | 2023-12-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004027288 | SCV004897974 | uncertain significance | Cardiovascular phenotype | 2023-11-28 | criteria provided, single submitter | clinical testing | The c.694+8_694+18del11 alteration is located in Intron 4 (E) of the LDLR gene. This alteration consists of a deletion of 11 nucleotides at nucleotide position c.6948 Intron 4 (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Clinical Genetics, |
RCV001700460 | SCV001918278 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001700460 | SCV001970208 | uncertain significance | not provided | no assertion criteria provided | clinical testing |